rs55659002
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000221930.6(TGFB1):c.713-8del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,614,128 control chromosomes in the GnomAD database, including 213 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 20 hom., cov: 31)
Exomes 𝑓: 0.015 ( 193 hom. )
Consequence
TGFB1
ENST00000221930.6 splice_region, splice_polypyrimidine_tract, intron
ENST00000221930.6 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.563
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-41342037-TG-T is Benign according to our data. Variant chr19-41342037-TG-T is described in ClinVar as [Benign]. Clinvar id is 197687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-41342037-TG-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.011 (1669/152248) while in subpopulation NFE AF= 0.0175 (1189/68010). AF 95% confidence interval is 0.0167. There are 20 homozygotes in gnomad4. There are 813 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB1 | NM_000660.7 | c.713-8del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000221930.6 | NP_000651.3 | |||
TGFB1 | XM_011527242.3 | c.713-5del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_011525544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFB1 | ENST00000221930.6 | c.713-8del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000660.7 | ENSP00000221930 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0110 AC: 1670AN: 152130Hom.: 20 Cov.: 31
GnomAD3 genomes
AF:
AC:
1670
AN:
152130
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0128 AC: 3207AN: 251012Hom.: 32 AF XY: 0.0132 AC XY: 1788AN XY: 135764
GnomAD3 exomes
AF:
AC:
3207
AN:
251012
Hom.:
AF XY:
AC XY:
1788
AN XY:
135764
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0149 AC: 21784AN: 1461880Hom.: 193 Cov.: 33 AF XY: 0.0148 AC XY: 10763AN XY: 727238
GnomAD4 exome
AF:
AC:
21784
AN:
1461880
Hom.:
Cov.:
33
AF XY:
AC XY:
10763
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0110 AC: 1669AN: 152248Hom.: 20 Cov.: 31 AF XY: 0.0109 AC XY: 813AN XY: 74442
GnomAD4 genome
AF:
AC:
1669
AN:
152248
Hom.:
Cov.:
31
AF XY:
AC XY:
813
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 03, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Sep 18, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at